Comparative Pharmacology
Head-to-head clinical analysis: PHOXILLUM B22K 4 0 IN PLASTIC CONTAINER versus PHYSIOSOL PH 7 4 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PHOXILLUM B22K 4 0 IN PLASTIC CONTAINER versus PHYSIOSOL PH 7 4 IN PLASTIC CONTAINER.
PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER vs PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
PHOXILLUM B22K 4/0 is a peritoneal dialysis solution containing bicarbonate/lactate as buffer. It corrects electrolyte imbalances, removes waste products (e.g., urea, creatinine) via diffusion and ultrafiltration across the peritoneal membrane. Bicarbonate helps correct metabolic acidosis.
Replacement of extracellular fluid and electrolytes; provides buffering capacity via bicarbonate precursor (acetate) and maintains physiological pH.
Intravenous infusion of 4 mmol/kg potassium phosphate per 24 hours, administered at a rate not exceeding 10 mmol/hour as part of total parenteral nutrition; typical adult dose: 30-40 mmol potassium phosphate per day.
Intravenous infusion, rate adjusted based on clinical status and electrolyte needs; typical adult dose is 500-1000 mL over 1-2 hours.
None Documented
None Documented
Terminal elimination half-life is approximately 0.5–1 hour in patients with normal renal function. In end-stage renal disease (ESRD), half-life extends to 6–8 hours, requiring dose adjustment.
Not applicable; components follow first-order kinetics with rapid redistribution. Lactate half-life ~15-30 minutes (hepatic metabolism).
Renal: 100% (proximal tubular secretion and glomerular filtration). Biliary/fecal: negligible (<1%).
Primarily renal; >95% of infused ions (sodium, chloride, lactate, calcium, magnesium) are excreted unchanged in urine. Biliary/fecal elimination negligible (<1%).
Category C
Category C
Irrigation Solution
Irrigation Solution